Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Merck | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Merck

Singulair expiry continues to impact results

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck

1Q Revenues: $10.7 billion (-9%)

1Q Earnings: $1.6 billion (-9%)

Comments: Pharmaceutical sales were $8.9 billion (-12%) due to patent expiries for Singulair, Maxalt and Clarinex. Gardasil sales were up 37% to $390 million. Remicade sales were up 5% to $549 million, Simponi sales were up 46% to $108 million. Isentress sales were up 8% to $362 million. Zetia sales were up 2% to $629 million. Consumer Care and Animal Health revenues were up 4% to $571 million and $840 million, respectively.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters